Drug: Ranibizumab Injury: Detachment of retinal pigment epithelium Quarter: 2016Q3
Total Records: 5 Number of Pages: 1
Event ID | DRUGNAME | PT | Drug Manufacturer | Patient Age | Sex | Weight | Date (YYYYMMDD) | Country |
---|---|---|---|---|---|---|---|---|
120983322 | Ranibizumab | Detachment of retinal pigment epithelium | ROCHE | 84.00 YR | F | 77 KG | 20160715 | DE |
121043734 | Ranibizumab | Detachment of retinal pigment epithelium | ROCHE | 81.00 YR | F | 69 KG | 20160905 | DE |
122176362 | Ranibizumab | Detachment of retinal pigment epithelium | ROCHE | 68.00 YR | F | 84 KG | 20160722 | DE |
125609491 | Ranibizumab | Detachment of retinal pigment epithelium | ROCHE | 0.00 | M | 0 | 20160715 | DE |
127611591 | Ranibizumab | Detachment of retinal pigment epithelium | ROCHE | 0.00 | F | 0 | 20160920 | DE |
Total Records: 5 Number of Pages: 1